NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT03424473 2020-02-25Expanded Access Use of Tucatinib for HER2+ Metastatic Breast CancerSeagen Inc.No longer available